The store will not work correctly when cookies are disabled.
5-(2,2-Dimethyl-[1,3]dioxolan-4-yl)-3,4-dihydroxy-5H-furan-2-one
ID: ALA2115433
Cas Number: 860649-42-9
PubChem CID: 54676508
Max Phase: Preclinical
Molecular Formula: C9H12O6
Molecular Weight: 216.19
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)OCC(C2OC(=O)C(O)=C2O)O1
Standard InChI: InChI=1S/C9H12O6/c1-9(2)13-3-4(15-9)7-5(10)6(11)8(12)14-7/h4,7,10-11H,3H2,1-2H3
Standard InChI Key: POXUQBFHDHCZAD-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 16 0 0 0 0 0 0 0 0999 V2000
5.2010 -4.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3868 -4.8022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1749 -4.0046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5001 -4.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8646 -3.5560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4023 -3.7055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1032 -2.9453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2848 -2.9910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0730 -3.7803 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7667 -4.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2977 -3.8634 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6123 -5.5500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9673 -5.5126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4872 -2.7709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4967 -2.1934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 1 1 0
5 4 1 0
6 3 1 0
7 6 1 0
8 7 1 0
9 10 1 0
10 6 1 0
11 4 2 0
12 1 1 0
13 2 1 0
14 8 1 0
15 8 1 0
5 3 1 0
8 9 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 216.19 | Molecular Weight (Monoisotopic): 216.0634 | AlogP: 0.39 | #Rotatable Bonds: 1 |
Polar Surface Area: 85.22 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.52 | CX Basic pKa: ┄ | CX LogP: -0.21 | CX LogD: -3.00 |
Aromatic Rings: ┄ | Heavy Atoms: 15 | QED Weighted: 0.62 | Np Likeness Score: 1.85 |
References
1. Abell AD, Ratcliffe MJ, Gerrard J.. (1998) Ascorbic acid-based inhibitors of alpha-amylases., 8 (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4] |
2. Abell AD, Ratcliffe MJ, Gerrard J.. (1998) Ascorbic acid-based inhibitors of alpha-amylases., 8 (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4] |
3. Al-Asri J, Fazekas E, Lehoczki G, Perdih A, Görick C, Melzig MF, Gyémánt G, Wolber G, Mortier J.. (2015) From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors., 23 (20): [PMID:26395057] [10.1016/j.bmc.2015.09.007] |